Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are over 18 years old
- You have a non-cancerous (benign) thyroid nodule that was treated with a heat-based procedure called radiofrequency thermoablation approximately 24 to 48 months ago (between 2 and 4 years ago), regardless of whether the nodule has stayed the same size, grown, or shrunk
- You are willing and able to sign a consent form agreeing to take part
- You are enrolled in the French social security system (note: AME — state medical aid for undocumented residents — does not qualify)
Who may not be able to join:
- Women who are pregnant or currently breastfeeding
- People who have previously had alcohol injected into their thyroid nodule as a treatment
- People who take a type of blood-thinning medication called anti-vitamin K anticoagulants (such as warfarin)
- People who take another type of blood-thinning medication called direct oral anticoagulants (such as rivaroxaban or apixaban)
- People who are currently under detention or held by a legal or administrative order
- People who are receiving involuntary psychiatric treatment
- People who are living in a health or social care facility for reasons unrelated to this research
- Adults who are under legal protection such as guardianship or a similar arrangement
- People who are unable to give their own consent to participate
- People under any form of legal protection measure (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01 84 82 77 59
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cytological change after thermoablation, as described by the 2017 Bethesda classification in six classes, scale ranging from I to VI.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.